You have 9 free searches left this month | to do more

nemtabrutinib

Nemtabrutinib is a drug used to treat Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, and other conditions. Nemtabrutinib is being actively studied in 2 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)A.O. Universitaria Policlinico S. Orsola-Malpighi ( Site 1400)
Merck Sharp & Dohme Corp.Ankara Universitesi Tip Fakultesi Cebeci Hastanesi ( Site 2400)
Centre Hospitalier Lyon-Sud ( Site 0804)
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Active, not recruiting
  • Lymphoma, B-Cell
  • +8 more
  • Nemtabrutinib
  • Scottsdale, Arizona
  • +9 more
2022-03-10
Mar 10, 2022
M
Recruiting
  • Hematologic Malignancies
  • Nemtabrutinib
  • Hackensack, New Jersey
  • +21 more
2022-04-07
Apr 7, 2022